SYNZYME TECHNOLOGY, INC.

Company Information

Company Name
SYNZYME TECHNOLOGY, INC.
Address
1 TECHNOLOGY DR, B-115
IRVINE, CA, 92618-
Phone
n/a
URL
n/a
DUNS
36552925
Number of Employees
n/a
Hubzone Owned:
N
Minority Owned:
N
Woman Owned:
N

Award Totals

PROGRAM/PHASE
AWARD AMOUNT ($)
NUMBER OF AWARDS
SBIR Phase I
$1,897,224.00
14
SBIR Phase II
$6,344,565.00
3

Award List

  1. Nitroxide Labeled Hemoglobin as a Blood Substitute

    Amount: $98,400.00

    A number of biopharmaceutical companies have successfully taken hemoglobin-based oxygen carriers (Hinto phase I clinical trial. However, transfusions have been limited to low dosage levels due to obsv ...

    SBIR Phase I 1995 Department of Health and Human Services
  2. N/A

    Amount: $100,000.00

    Not Available Aspen Systems proposes to develop new Ultra-High Temperature Resistant Aerogels that will withstand temperatures as high as 2300 K for long periods of time. The new insulation will be ba ...

    SBIR Phase I 2000 Department of Health and Human Services
  3. PND (POLYNITROXYL-DEXTRAN): GUT PROTECTION AFTER SHOCK

    Amount: $100,000.00

    Not Available The subject program seeks to design, develop, and fabricate a miniature actuation and control system suitable for the control of pinnate position on a tactical solid rocket motor (SRM). ...

    SBIR Phase I 1999 Department of Health and Human Services
  4. POLYNITROXYL HEMOGLOBIN:NEUROPROTECTIVE OXYGEN CARRIER

    Amount: $100,044.00

    DESCRIPTION: (Investigator's abstract) Polynitroxyl hemoglobin (PNH) will be developed as a neuroprotective oxygen carrier. PNH is different from 1st generation hemoglobin-based ox ...

    SBIR Phase I 2001 Department of Health and Human Services
  5. NITROXIDE THERAPY FOR INFLAMMATORY BOWEL DISEASE

    Amount: $100,000.00

    DESCRIPTION (Adapted from the application): Free radicals play important roles in inflammatory bowel disease (IBD), and the reduction or elimination of the adverse effects of these oxida ...

    SBIR Phase I 2001 Department of Health and Human Services
  6. TOPS-ESTER MODULATION OF UVB-INDUCED IMMUNE SUPPRESSION

    Amount: $98,736.00

    DESCRIPTION (provided by applicant): A TOPS-ester, diethyl 2,2,6,6-tetramethyl-1-oxyl-4-piperidene succinate (DETOPS), is a topical drug selected for development for its unique ability to compartment ...

    SBIR Phase I 2002 Department of Health and Human Services
  7. TOPS-Ester: Pharmacokinetics and Imaging in Human Skin

    Amount: $100,003.00

    DESCRIPTION (provided by applicant): TOPS-ester is a topical drug selected for development for it's unique ability to compartmentalize within skin cells and express antioxidant activity that limits ox ...

    SBIR Phase I 2003 Department of Health and Human Services
  8. Brain Injury During CPR Prevented by Vascular Nitroxide

    Amount: $100,004.00

    DESCRIPTION (provided by applicant): The brain damage that frequently accompanies cardiac arrest and resuscitation is devastating. Fewer than 10% of cardiopulmonary resuscitation (CPR) attempts resul ...

    SBIR Phase I 2003 Department of Health and Human Services
  9. PNA for Stroke

    Amount: $2,928,858.00

    DESCRIPTION (provided by applicant): Stroke is the 3rd leading cause of death in the U.S. and is also a leading cause of severe, long-term disability. The total cost of stroke to the United States is ...

    SBIR Phase II 2005 Department of Health and Human Services
  10. EYNZYMES IN HEART

    Amount: $100,000.00

    N/A

    SBIR Phase I 1996 Department of Health and Human Services

Agency Micro-sites


SBA logo

Department of Agriculture logo

Department of Commerce logo

Department of Defense logo

Department of Education logo

Department of Energy logo

Department of Health and Human Services logo

Department of Homeland Security logo

Department of Transportation logo

Enviromental Protection Agency logo

National Aeronautics and Space Administration logo

National Science Foundation logo
US Flag An Official Website of the United States Government